| Literature DB >> 29769703 |
João Sérgio Neves1,2, Pedro Souteiro3,4, Sofia Castro Oliveira3,4, Jorge Pedro3, Daniela Magalhães3,4, Vanessa Guerreiro3, Maria Manuel Costa3,4, Rita Bettencourt-Silva3,4, Ana Cristina Santos5,6, Joana Queirós3,7, Ana Varela3,4,7, Paula Freitas3,4,7,8, Davide Carvalho3,4,8.
Abstract
Thyroid function has an important role on body weight regulation. However, the impact of thyroid function on weight loss after bariatric surgery is still largely unknown. We evaluated the association between preoperative thyroid function and the excess weight loss 1 year after surgery, in 641 patients with morbid obesity who underwent bariatric surgery. Patients with a history of thyroid disease, treatment with thyroid hormone or antithyroid drugs and those with preoperative evaluation consistent with overt hypothyroidism or hyperthyroidism were excluded. The preoperative levels of TSH and FT4 were not associated with weight loss after bariatric surgery. The variation of FT3 within the reference range was also not associated with weight loss. In contrast, the subgroup with FT3 above the reference range (12.3% of patients) had a significantly higher excess weight loss than patients with normal FT3. This difference remained significant after adjustment for age, sex, BMI, type of surgery, TSH and FT4. In conclusion, we observed an association between high FT3 and a greater weight loss after bariatric surgery, highlighting a group of patients with an increased benefit from this intervention. Our results also suggest a novel hypothesis: the pharmacological modulation of thyroid function may be a potential therapeutic target in patients undergoing bariatric surgery.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29769703 DOI: 10.1038/s41366-018-0071-8
Source DB: PubMed Journal: Int J Obes (Lond) ISSN: 0307-0565 Impact factor: 5.095